Kinepolis Group NV/€KIN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Kinepolis Group NV
Kinepolis Group NV is a Belgian company operating in the film exhibition industry. It specializes in managing multiplex cinema complexes and offers a wide range of film-related entertainment services. Established in 1997, the company was founded through a merger of two family businesses, Bert and Claeys, which already had a history in film exhibition. Kinepolis's headquarters are located in Ghent, Belgium, and the company has expanded its footprint across several European countries and Canada. It differentiates itself through innovative cinema designs, advanced technology integration, and a focus on enhancing customer experience, allowing it to maintain a competitive position in the market.
- Ticker
- €KIN
- Sector
- Consumer Discretionary
- Primary listing
- BSE
- Employees
- 5,000
- Headquarters
- Brussels, Belgium
- Website
- www.kinepolis.com
KIN Metrics
BasicAdvanced
€1.3B
21.55
€2.23
0.41
€0.46
0.95%
Price and volume
Market cap
€1.3B
Beta
0.41
52-week high
€49.70
52-week low
€24.55
Average daily volume
47K
Dividend rate
€0.46
Financial strength
Current ratio
0.606
Quick ratio
0.579
Long term debt to equity
3.004
Total debt to equity
4.112
Dividend payout ratio (TTM)
30.93%
Interest coverage (TTM)
3.39%
Profitability
EBITDA (TTM)
160.938
Gross margin (TTM)
25.93%
Net profit margin (TTM)
8.66%
Operating margin (TTM)
16.63%
Effective tax rate (TTM)
24.69%
Revenue per employee (TTM)
€130,000
Management effectiveness
Return on assets (TTM)
5.49%
Return on equity (TTM)
25.32%
Valuation
Price to earnings (TTM)
21.546
Price to revenue (TTM)
1.815
Price to book
4.42
Price to tangible book (TTM)
-41.69
Price to free cash flow (TTM)
8.384
Free cash flow yield (TTM)
11.93%
Free cash flow per share (TTM)
5.729
Dividend yield (TTM)
0.95%
Forward dividend yield
0.95%
Growth
Revenue change (TTM)
9.36%
Earnings per share change (TTM)
26.28%
3-year revenue growth (CAGR)
5.21%
10-year revenue growth (CAGR)
7.33%
3-year earnings per share growth (CAGR)
15.59%
10-year earnings per share growth (CAGR)
7.04%
3-year dividend per share growth (CAGR)
35.72%
10-year dividend per share growth (CAGR)
-1.93%
What the Analysts think about KIN
Analyst ratings (Buy, Hold, Sell) for Kinepolis Group NV stock.
Analyst projections of the future price of Kinepolis Group NV stock.
Bulls say / Bears say
Kinepolis is benefiting from a stronger film slate: third-quarter attendance rose 49.1% year on year, with like-for-like visitor and revenue growth, and the company says it is on track for a record 2026. (Kinepolis Group)
Premium formats and higher spending per visitor are lifting earnings quality. Kinepolis reported that revenue per visitor continued to rise in Q3, while EBITDAL and net profit grew faster than revenue. (Kinepolis Group, Kinepolis Group)
US expansion gives Kinepolis a larger platform and potential to improve acquired sites. Showcase brings 13 cinemas and more than $90 million in 2025 revenue, while its $30 million enterprise value was largely covered by the real estate value of its owned locations. (Kinepolis Group)
Results remain exposed to the hit-driven film calendar: management attributed Q3's record to major releases and warned that some films will disappoint while others outperform. It gave no specific attendance guidance for the second half. (Stock Analysis)
A weaker US or Canadian dollar can erode reported growth even when local operations improve. Kinepolis cited adverse currency effects on revenue in both its H1 and Q3 updates. (Kinepolis Group, Kinepolis Group)
The US acquisitions bring execution risk as well as scale. Showcase generated only approximately break-even theatre-level cash flow in 2025, and management described it as underperforming and requiring restructuring. (Kinepolis Group, Stock Analysis)
Data summarised monthly by Lightyear AI. Last updated on 26 Oct 2026.
KIN Financial Performance
Revenues and expenses
KIN Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing KIN
AllUSDEURGBP
Fund name | Fund size | €KIN weighting |
|---|---|---|
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.05% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.05% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap£WLDS | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | $9B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.